Neurons that express neuronal nitric-oxide synthase (nNOS) are resistant to NO-induced neurotoxicity; however, the mechanism by which these neurons are protected is not clear. To identify proteins possibly involved in this process, we performed affinity chromatography with the nNOS PDZ domain, a N-terminal motif that mediates protein interactions. Using this method to fractionate soluble tissue extracts, we identified the muscle isoform of phosphofructokinase (PFK-M) as a protein that binds to nNOS both in brain and skeletal muscle. PFK-M interacts with the PDZ domain of nNOS, and nNOS-PFK-M binding can be competed by peptides that bind to the PDZ domain of nNOS. We found that nNOS is significantly associated with PFK-M in skeletal muscle because nNOS can be immunodepleted from cytosolic skeletal muscle extracts using an antibody directed against PFK-M. In brain, nNOS and PFK-M are both enriched in synaptosomes, and specifically, in the synaptic vesicle fraction, where they can interact. At the cellular level, PFK-M is enriched in neurons that express nNOS protein. As fructose-1,6-bisphosphate, the product of PFK activity, is neuroprotective, the interaction of nNOS and PFK may contribute to neuroprotection of nNOS positive cells.Nitric oxide, derived from neuronal nitric-oxide synthase (nNOS), 1 has important physiological functions in the nervous system (1, 2). In the peripheral nervous system, NO mediates certain actions of autonomic motor neurons on smooth muscle and thereby NO regulates intestinal peristalsis and penile erection. In the central nervous system, NO does not primarily act on smooth muscle but instead modulates synaptic transmission associated with N-methyl-D-aspartate (NMDA) type glutamate receptors. By regulating synaptic plasticity, NO can influence hippocampal long term potentiation (3) as well as aspects of learning (4) and memory (5).Although small amounts of NO mediate physiological signaling, excess NO production can cause tissue injury (6). The primary stimulus for NO synthesis in central neurons is activation of NMDA receptors (2). Overactivity of NMDA receptors is implicated in numerous neurodegenerative processes including stroke, Huntington's chorea, and amyotrophic lateral sclerosis (7). A role for NO in NMDA-mediated degeneration was first suggested by experiments showing neuroprotection by NO synthase antagonists (8). Definitive evidence that nNOS mediates brain injury derives from studies of nNOS knockout mice, which are strikingly resistant to excitotoxicity following focal cerebral ischemia (9).NO can mediate neurotoxicity by inhibiting metabolic pathways and causing cellular energy depletion, which is a hallmark of ischemic injury-induced neuronal death. NO erodes energy stores by reacting with certain metabolic enzymes that contain heme-iron prosthetic groups, iron-sulfur clusters, or reactive thiols (10). Through these reactions, NO can inhibit glycolysis by reacting with cis-aconitase and can attenuate oxidative phosphorylation by inhibiting mitochondrial iron-sulfur enzy...